StockData
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) stock

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$23.76−1.06 (-4.27%)

Close on Nov 17, 2026Market cap $1.14BP/E –Yield –

Rapport Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Rapport Therapeutics's enterprise value was $859.67M on Nov 11, 2026, against $902.69M a year earlier. Over the last 3 years it ranged from -$52.72M to $1.90B, with a median of $754.97M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$859.67M-7.8%
2025Dec 31, 2025$932.71M+184.2%
2024Dec 31, 2024$328.17M–

More Rapport Therapeutics figures

See a number that looks wrong?